Table: monthly_update_prescription_drug_wac_inc , manufacturer_name like K*

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  *

oshpd_id manufacturer_name date_reported ndc_number drug_product_description wac_effective_date wac_increase_amount wac_after_increase patent_expiration_date drug_source_type unit_sales_volume_in_us unit_sales_volume_non_public_indicator gross_sales_us_dollars gross_sales_us_dollars_non_public_indicator cost_increase_factors cost_increase_factors_non_public_indicator change_improvement_description change_improvement_non_public_indicator acquisition_date company_acquired_from acquisition_price acquisition_price_non_public_indicator acquisition_price_comment wac_at_acquisition wac_year_prior_to_acquisition year_drug_introduced_to_market wac_at_intro_to_market supporting_documents general_comments
Rx0000127 Karyopharm Therapeutics Inc. 04/23/2025 72237010305 Xpovio (100 MG Once Weekly) Oral Tablet Therapy Pack 50 MG 01/01/2025 2117.00 32787.00 08/14/2035 Single Source Drug None None None 1 None 1 None 1 None None None None None None None None None None None
Rx0000127 Karyopharm Therapeutics Inc. 04/23/2025 72237010207 Xpovio (40 MG Once Weekly) Oral Tablet Therapy Pack 40 MG 01/01/2025 2117.00 32787.00 08/14/2035 Single Source Drug None None None 1 None 1 None 1 None None None None None None None None None None None
Rx0000127 Karyopharm Therapeutics Inc. 04/23/2025 72237010206 Xpovio (40 MG Twice Weekly) Oral Tablet Therapy Pack 40 MG 01/01/2025 2117.00 32787.00 08/14/2035 Single Source Drug None None None 1 None 1 None 1 None None None None None None None None None None None
Rx0000127 Karyopharm Therapeutics Inc. 04/23/2025 72237010401 Xpovio (60 MG Once Weekly) Oral Tablet Therapy Pack 60 MG 01/01/2025 2117.00 32787.00 08/14/2035 Single Source Drug None None None 1 None 1 None 1 None None None None None None None None None None None
Rx0000127 Karyopharm Therapeutics Inc. 04/23/2025 72237010103 Xpovio (60 MG Twice Weekly) Oral Tablet Therapy Pack 20 MG 01/01/2025 2117.00 32787.00 08/14/2035 Single Source Drug None None None 1 None 1 None 1 None None None None None None None None None None None
Rx0000127 Karyopharm Therapeutics Inc. 04/23/2025 72237010202 Xpovio (80 MG Once Weekly) Oral Tablet Therapy Pack 40 MG 01/01/2025 2117.00 32787.00 08/14/2035 Single Source Drug None None None 1 None 1 None 1 None None None None None None None None None None None
Rx0000127 Karyopharm Therapeutics Inc. 04/23/2025 72237010104 Xpovio (80 MG Twice Weekly) Oral Tablet Therapy Pack 20 MG 01/01/2025 2117.00 32787.00 08/14/2035 Single Source Drug None None None 1 None 1 None 1 None None None None None None None None None None None
Rx0000264 Kedrion Biopharma Inc. 01/02/2025 76125090010 gammaked 10% carton w/ 1 x 100ml vial 01/01/2025 46.61 1027.92 None Single Source Drug None None None 1 None 1 None 1 None None None None None None None None None None Kedrion’s price increase factors, costs, and revenue constitute trade secret information and are exempt from disclosure
Rx0000264 Kedrion Biopharma Inc. 01/02/2025 76125090001 gammaked 10% carton w/ 1 x 10ml vial 01/01/2025 9.32 205.58 None Single Source Drug None None None 1 None 1 None 1 None None None None None None None None None None Kedrion’s price increase factors, costs, and revenue constitute trade secret information and are exempt from disclosure
Rx0000264 Kedrion Biopharma Inc. 01/02/2025 76125090020 gammaked 10% carton w/ 1 x 200ml vial 01/01/2025 93.22 2055.83 None Single Source Drug None None None 1 None 1 None 1 None None None None None None None None None None Kedrion’s price increase factors, costs, and revenue constitute trade secret information and are exempt from disclosure
Rx0000264 Kedrion Biopharma Inc. 01/02/2025 76125090050 gammaked 10% carton w/ 1 x 50ml vial 01/01/2025 186.45 4111.68 None Single Source Drug None None None 1 None 1 None 1 None None None None None None None None None None Kedrion’s price increase factors, costs, and revenue constitute trade secret information and are exempt from disclosure
Rx0000386 KVK Tech, Inc. 04/14/2025 10702000125 Lomaira Oral Tablet 8 MG 250ct 02/06/2025 29.12 149.95 None Non-innovator Multiple Source Drug None None 650 None Inflation based on the Consumer Price Index (CPI) None None 1 None None None None None None None None None None Drug was not acquired within the last 5 years
Rx0000386 KVK Tech, Inc. 04/14/2025 10702000109 Lomaira Oral Tablet 8 MG 90ct 01/01/2025 4.83 57.97 None Non-innovator Multiple Source Drug None None 142000 None Inflation based on the Consumer Price Index (CPI) None None 1 None None None None None None None None None None Drug was not acquired within the last 5 years
Rx0000386 KVK Tech, Inc. 02/19/2025 10702007106 Oxymorphone 10mg 60ct 02/17/2025 226.86 248.00 None Non-innovator Multiple Source Drug None None 779424 None The cost of raw material increases. The cost of DEA compliance/SOMS has also increased exponentially with the nationwide opioid litigation None None 1 None None None None None None None None None None Drug was not acquired within the last 5 years
Rx0000386 KVK Tech, Inc. 02/19/2025 10702007006 Oxymorphone 5mg 60ct 02/17/2025 80.27 101.00 None Non-innovator Multiple Source Drug None None 1 None The cost of raw material increases. The cost of DEA compliance/SOMS has also increased exponentially with the nationwide opioid litigation None None 1 None None None None None None None None None None Drug was not acquired within the last 5 years Also- we had $0 in sales for that NDC, and it was giving me an error, so I just plugged in $1